DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Share Price

Certificat

DE000ME88W58

Real-time Bid/Ask 17:01:23 03/07/2024 BST
108.37 EUR / 108.4 EUR -1.05% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.30%
1 month+2.72%
Date Price Change
03/07/24 109 -0.49%
02/07/24 109.5 -0.37%
01/07/24 110 +0.07%
28/06/24 109.9 -0.04%
27/06/24 109.9 -0.17%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 12:53 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME88W5
ISINDE000ME88W58
Date issued 06/02/2024
Cap 120 $
Last trading day 20/09/2024
Maturity 20/09/2024 (79 Days)
Parity 1 : 1
Emission price 99.36
Emission volume N/A
Payment day 27/09/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 15.13 %
Sideways yield 2.470 %
Sideways yield pa 11.41 %
Outperformance point 141.4 $
Break even 117.11 €
Highest since issue 110.1
Lowest since issue 98.54
Spread 0.03
Spread %0.03%
Distance Cap 17.53 $
Distance Cap %+12.75%
Max. earning 2.677
Max. earning % 2.470 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus